Analyst Expectations For Amgen's Future
Portfolio Pulse from Benzinga Insights
Amgen (NASDAQ:AMGN) has received mixed analyst ratings over the past three months, with a recent positive shift in average price targets. Analysts have varied in their recommendations, with some raising and others lowering their price targets. Amgen's financial performance shows strong net margins and ROE, but challenges in debt management.

September 25, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amgen has received a mix of bullish and bearish analyst ratings, with a recent positive shift in average price targets. Analysts have varied in their recommendations, with some raising and others lowering their price targets. Amgen's financial performance shows strong net margins and ROE, but challenges in debt management.
The article provides a detailed analysis of Amgen's recent analyst ratings, showing a mix of bullish and bearish perspectives. The average price target has increased, indicating a positive sentiment shift. However, the mixed ratings and financial challenges, such as high debt-to-equity ratio, suggest a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100